Paracetamolforgiftninger etter innføring av ny salgsordning

Tidsskrift for den Norske Laegeforening

Volumn 131, Issue 21, 2011, Pages 2115-2118

  Haga, Christian ^a   Muan, Berit ^a   Cheung, Monica ^b   Lyngra, Mariann ^c   Strømsæther, Carl Erik ^a   Lutro, Olav ^d   Andrew, Erik ^a  

^a Helsedirektoratet ^*  (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NON PRESCRIPTION DRUG; PARACETAMOL;

ARTICLE; BLOOD; DRUG CONTROL; DRUG UTILIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTOXICATION; LEGAL ASPECT; LIVER TRANSPLANTATION; MORTALITY; NORWAY; POISON CENTER; REGISTER; STATISTICS; TOXIC HEPATITIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; DRUG AND NARCOTIC CONTROL; DRUG UTILIZATION; DRUG-INDUCED LIVER INJURY; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; NONPRESCRIPTION DRUGS; NORWAY; OVERDOSE; PATIENT ADMISSION; POISON CONTROL CENTERS; REGISTRIES;

EID: 81255148052     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.10.1441     Document Type: Article

References (14)

1. Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf 2007; 30: 465-79.
2. Lystbaek BB, Svendsen LB, Heslet L. Paracetamolforgiftning. Ugeskr Læger 1995; 157: 869-73.
3. Bøe GH, Haga C, Andrew E et al. Paracetamolforgiftninger i Norge 1990-2001. Tidsskr Nor Lægeforen 2004; 124: 1624-8.
4. Aakvik R, Jacobsen D. Paracetamolforgiftning-forekomst og behandling. Tidsskr Nor Lægeforen 2006; 126: 1731-3.
5. Watkins PB, Kaplowitz N, Slattery JT et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily. A randomized controlled trail. JAMA 2006; 296: 87-93.
6. Helsedirektoratet, avdeling for Giftinformasjon. Paracetamol-behandlingsanbefaling ved forgiftning. www.helsebiblioteket.no (15.10.2010).
7. Legemiddelforbruket i Norge 2000-2004. Oslo: Nasjonalt folkehelseinstitutt, 2005.
8. Nasjonalt folkehelseinstitutt. Legemiddelforbruket i Norge 2005-2009. www.legemiddelforbruk.no (11.10.2010).
9. Bateman DN, Gorman DR, Bain M et al. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol 2006; 62: 573-81.
10. Gunnell D, Hawton K, Murray V et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health 1997; 51: 175-9.
11. Prior MJ, Cooper K, Cummins P et al. Acetaminophen availability increases in Canada with no increase in the incidence of reports of inpatient hospitalizations with acetaminophen overdose and acute liver toxicity. Am J Ther 2004; 11: 443-52.
12. Myers RP, Li B, Fong A et al. Hospitalizations for acetaminophen overdose: a Canadian populationbased study from 1995 to 2004. BMC Public Health 2007; 7: 143.
13. Baumert J, Erazo N, Ruf E et al. Time trends in suicide mortality vary in choice of methods: an analysis of 145,865 fatal suicide cases in Germany 1991-2002. Soc Psychiatry Psychiatr Epidemiol 2008; 43: 913-9.
14. Muan B, Heyerdahl F, Lindås R et al. Kodepraksis ved forgiftningsdødsfall. Tidsskr Nor Legeforen 2010; 130: 1601-5.